Ignite Creation Date:
2025-12-25 @ 4:31 AM
Ignite Modification Date:
2026-02-10 @ 4:28 AM
Study NCT ID:
NCT04102618
Status:
TERMINATED
Last Update Posted:
2022-08-15
First Post:
2019-09-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Window-of-opportunity Study of Pelareorep in Early Breast Cancer
Sponsor:
Oncolytics Biotech
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Breast Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Breast | View |
| None | Breast Cancer | View |
| None | Primary Breast | View |
| None | Primary Breast Cancer | View |
| None | Pelareorep | View |
| None | Atezolizumab | View |
| None | Reovirus | View |
| None | Oncolytic virus | View |
| None | Letrozole | View |
| None | Early Breast Cancer | View |
| None | Triple-negative breast cancer | View |
| None | HR+ breast cancer | View |
| None | HER2+ breast cancer | View |